» Articles » PMID: 7510715

Epitopes on the Beta Subunit of Human Muscle Acetylcholine Receptor Recognized by CD4+ Cells of Myasthenia Gravis Patients and Healthy Subjects

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1994 Mar 1
PMID 7510715
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the sequence regions of the human muscle acetylcholine receptor (AChR) beta subunit forming epitopes recognized by T helper cells in myasthenia gravis (MG), using overlapping synthetic peptides, 20 residues long, which screened the sequence of the AChR beta subunit. Since CD4+ lymphocytes from MG patients' blood did not respond to the peptides, we attempted propagation of beta subunit-specific T lines from six MG patients and seven healthy controls by cycles of stimulation of blood lymphocytes with the pooled peptides corresponding to the beta subunit sequence. CD4+ T lines were obtained from four patients and three controls. They secreted IL-2, not IL-4, suggesting that they comprised T helper type 1 cells. The T lines from MG patients could be propagated for several months. Three lines were tested with purified bovine muscle AChR and cross-reacted well with this antigen. All T lines were tested with the individual synthetic peptides present in the pool corresponding to the beta subunit sequence. Several beta subunit peptide sequences were recognized. Each line had an individual pattern of peptides recognition, but three sequence regions (peptides beta 181-200, beta 271-290, and the overlapping peptides beta 316-335 and beta 331-350) were recognized by most MG lines. The beta subunit-specific T lines from controls could be propagated for < 5 wk. Each line recognized several peptides, which frequently included the immunodominant regions listed above.

Citing Articles

Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.

Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, OConnor K J Immunol. 2016; 196(5):2075-84.

PMID: 26826242 PMC: 4761502. DOI: 10.4049/jimmunol.1501339.


Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Yi J, Guidon A, Sparks S, Osborne R, Juel V, Massey J J Autoimmun. 2014; 52:130-8.

PMID: 24378287 PMC: 4230445. DOI: 10.1016/j.jaut.2013.12.005.


Myasthenia gravis: past, present, and future.

Conti-Fine B, Milani M, Kaminski H J Clin Invest. 2006; 116(11):2843-54.

PMID: 17080188 PMC: 1626141. DOI: 10.1172/JCI29894.


Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Yang H, Goluszko E, David C, Okita D, Conti-Fine B, Chan T J Clin Invest. 2002; 109(8):1111-20.

PMID: 11956249 PMC: 150946. DOI: 10.1172/JCI14255.


Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.

Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel R J Clin Invest. 1998; 102(10):1831-40.

PMID: 9819369 PMC: 509133. DOI: 10.1172/JCI4213.


References
1.
Delisi C, Berzofsky J . T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci U S A. 1985; 82(20):7048-52. PMC: 391307. DOI: 10.1073/pnas.82.20.7048. View

2.
Hohlfeld R, Kalies I, Bertrams J, Toyka K . Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis. J Immunol. 1985; 135(4):2393-9. View

3.
Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Toyka K . Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology. 1986; 36(5):618-21. DOI: 10.1212/wnl.36.5.618. View

4.
Levinson A, Zweiman B, Lisak R . Immunopathogenesis and treatment of myasthenia gravis. J Clin Immunol. 1987; 7(3):187-97. DOI: 10.1007/BF00915723. View

5.
Oldstone M . Molecular mimicry and autoimmune disease. Cell. 1987; 50(6):819-20. DOI: 10.1016/0092-8674(87)90507-1. View